Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-12 8:30 pm Purchase |
2025-03-10 | 13D | Aligos Therapeutics, Inc. ALGS |
Lawrence M. Blatt, Ph.D. | 175,509 3.200% |
175,509 (New Position) |
Filing History |
| 2025-02-14 4:56 pm Sale |
2024-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
Armistice Capital, LLC | 188,438 4.990% |
-131,318 (-41.07%) |
Filing History |
| 2025-02-12 09:32 am Purchase |
2024-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
Adage Capital Management L.P. | 325,000 9.380% |
106,187 (+48.53%) |
Filing History |
| 2024-11-14 6:57 pm Purchase |
2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS |
Vivo Capital Fund VIII L.P. | 141,879 4.000% |
141,879 (New Position) |
Filing History |
| 2024-11-14 6:19 pm Purchase |
2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS |
EcoR1 Capital LLC | 356,117 9.990% |
356,117 (New Position) |
Filing History |
| 2024-11-14 5:03 pm Purchase |
2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS |
Armistice Capital, LLC | 319,756 9.990% |
319,756 (New Position) |
Filing History |
| 2024-11-14 4:37 pm Sale |
2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS |
Alyeska Investment Group, L.P. | 146,472 4.800% |
-140,599 (-48.98%) |
Filing History |
| 2024-11-14 4:34 pm Purchase |
2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS |
HHLR Advisors, Ltd. | 125,069 4.000% |
125,069 (New Position) |
Filing History |
| 2024-11-12 09:31 am Purchase |
2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS |
Adage Capital Management L.P. | 218,813 7.120% |
218,813 (New Position) |
Filing History |
| 2024-09-12 4:21 pm Purchase |
2024-09-09 | 13G | Aligos Therapeutics, Inc. ALGS |
ICS OPPORTUNITIES II LLC | 125,451 4.100% |
125,451 (New Position) |
Filing History |
| 2024-02-14 5:07 pm Purchase |
2023-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
EcoR1 Capital LLC | 290,566 9.990% |
132,631 (+83.98%) |
Filing History |
| 2024-02-14 4:37 pm Purchase |
2023-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
HHLR Advisors, Ltd. | 238,857 8.200% |
146,466 (+158.53%) |
Filing History |
| 2024-02-14 4:21 pm Purchase |
2023-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
Baker Bros. Advisors LP | 146,561 4.990% |
63,505 (+76.46%) |
Filing History |
| 2024-02-14 4:00 pm Sale |
2023-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
TANG CAPITAL PARTNERS LP | 87,594 3.000% |
-25,062 (-22.25%) |
Filing History |
| 2024-02-14 3:23 pm Purchase |
2023-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
Armistice Capital, LLC | 288,593 9.990% |
288,593 (New Position) |
Filing History |
| 2024-02-14 1:53 pm Purchase |
2023-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
Alyeska Investment Group, L.P. | 287,071 9.990% |
287,071 (New Position) |
Filing History |
| 2024-02-08 5:44 pm Unchanged |
2023-11-02 | 13D | Aligos Therapeutics, Inc. ALGS |
Versant Venture Capital VI, L.P. | 58,317 1.900% |
0 (Unchanged) |
Filing History |
| 2023-11-07 5:16 pm Purchase |
2023-10-25 | 13G | Aligos Therapeutics, Inc. ALGS |
Roche Finance Ltd | 441,038 15.350% |
317,344 (+256.56%) |
Filing History |
| 2023-11-06 4:05 pm Purchase |
2023-10-25 | 13D | Aligos Therapeutics, Inc. ALGS |
Lawrence M. Blatt, Ph.D. | 155,530 5.300% |
48,411 (+45.19%) |
Filing History |
| 2023-11-02 4:08 pm Purchase |
2023-10-23 | 13G | Aligos Therapeutics, Inc. ALGS |
Deep Track Capital, LP | 291,839 9.990% |
291,839 (New Position) |
Filing History |